Insulin Potentiation Therapy, generally known by the initials IPT, is another treatment that uses standard, approved cancer-fighting drugs in lower doses, thereby eliminating a number of the debilitating side effects so common with traditional chemotherapy.

Side effects

The side effects are significantly reduced since the chemotherapy doses can be as low as 10-15% of the normal dosage. IPT was designed by Dr. Donato Perez Garcia (1896-1971) in Mexico, who promised it to be particularly successful with breast cancer. Indeed, that if a cancer could be beneficially affected by existing chemotherapy drugs, then IPT might also be effective, but without significant side effects.

Dr Garcia’s job is now carried on by his grandson, of the identical name. The first clinical trial of IPT for treating breast cancer has been undertaken in Uruguay and published in 2003. For the trial, insulin along with the chemotherapy drug methotrexate in low-dose form led to significantly stabilising the disease, with decreased progressions, when compared with insulin or low-dose methotrexate alone.

Research

Other studies have been globally, although casual. In actuality, although little known, IPT has been used for approaching seventy years. How can IPT work? Insulin, which is created naturally in the pancreas, regulates many of the body’s functions at the cellular level, the most well-known being the amount of sugar in the blood. It’s recommended that insulin also modifies the receptivity of cancer cells into be penetrated by chemotherapy agents.

Cancer cells grow by secreting their particular insulin-like growth factor and insulin which draw on the body’s nutrients to multiply. The truth is they have many times more insulin receptors than do normal cells, and these receptors will react to modulates insulin, which then makes them hungry for sugar and thus more vulnerable to chemotherapy medication.

Did you know?

The chemotherapy drugs are consequently able to target more precisely the cancer cells, leaving the normal cells comparatively unaffected. What’s wrong with conventional chemotherapy? It’s usually recognized that, over time, regular chemotherapy dosages may so endanger a patient’s immune system and organ acts as to stop additional treatment or even trigger organ damage leading to the patient’s death.

Cancer cells are highly effective in fighting for the sugar found in the blood flow. With sixteen times the amount of insulin and insulin-like receptors found in healthy cells, cancer cells absorb essential nutrients in the blood flow before normal cells may get to them. This is why, in advanced stages of cancer, tumors continue to grow and multiply while the individual seems to waste away.

Additionally, due to the cancer cell’s internal defense against poisons, normal chemotherapy dosages will need to be sufficiently large to force their way to the cancer cells. IPT works aggressively against cancerous tumors whilst being gentle to the patient, who continues to live a normal lifestyle during therapy.

Keep in mind

Standard chemotherapy medications are deemed to work better in conjunction with IPT. As a consequence of the low dose condition and much reduced toxicity, the treating doctor has greater flexibility and freedom in choosing and combining the various chemotherapeutic agents, leading to a more highly optimized treatment. As a result of reduced dose requirements, treatments costs are significantly less compared to conventional chemotherapy. Side effects are relatively minor.

There’s absolutely no vomiting, no high fever, no vomiting and no hair loss. However, there may sometimes be a little preliminary nausea and occasional constipation. IPT causes a decline in the blood sugar level. This is referred to as hypoglycemia and is an expected side effect of insulin treatment. Be in no doubt, hypoglycemia is a potentially dangerous condition for the human body, however it’s a condition that’s quickly and efficiently controllable through the administration of intravenous glucose infusions. This is a standard part of the IPT protocol.

Conclusion

The information presented here is meant simply as that – to make you aware of available remedies which could be worthy of further and more detailed analysis. Readers should note that, whilst there are lots of individual anecdotal cases and studies over several years that indicate that IPT may be effective, there is at present no set of scientific information to confirm Insulin Potentiation Therapy as a treatment for malignant neoplastic diseases or cancer to the satisfaction of the United States FDA. As always, you should seek the advice of a professional medical practitioner before taking any drugs or undergoing any sort of therapy.